Clinical Trial Update: Lexapro for Major Depression in Patients With Epilepsy [Phase 4]

View source ↗

Summary

A Phase 4 trial evaluating Lexapro (escitalopram) for major depressive disorder in patients with epilepsy was terminated, with results posted in 2015.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Epilepsy
• Major Depressive Disorder

Drugs mentioned

• Lexapro (escitalopram)

Snippet

Sponsor: Weill Medical College of Cornell University | Conditions: Major Depression, Epilepsy | Phase 4 | Status: TERMINATED | Results posted: 2015-08-03